Endra Life Sciences Inc (NDRA): Very nice dip opportunity here.

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Endra Life Sciences Inc (NDRA)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	62
Posts	6913
Boards Moderated	1
Alias Born	02/02/2017

Re: None

Wednesday, 07/01/2020 1:26:34 PM

Wednesday, July 01, 2020 1:26:34 PM

Very nice dip opportunity here.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent NDRA News

Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 08:10:30 PM
ENDRA Life Sciences Announces Reverse Stock Split • Business Wire • 08/16/2024 12:00:00 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2024 09:00:03 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:06:44 PM
ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024 • Business Wire • 08/13/2024 08:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 01:24:59 PM
ENDRA Life Sciences Announces Leadership Changes • Business Wire • 08/13/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 12:02:42 PM
ENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14 • Business Wire • 08/07/2024 12:00:00 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/17/2024 08:16:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 08:16:45 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 06/14/2024 08:01:26 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 06/14/2024 12:00:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 12:00:40 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/05/2024 04:15:12 AM
ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering • Business Wire • 06/04/2024 01:21:00 PM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/31/2024 08:21:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 12:05:32 PM
ENDRA Provides Update Following In-person Meeting with FDA • Business Wire • 05/20/2024 12:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:26:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:17:00 PM
ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update • Business Wire • 05/14/2024 08:05:00 PM

More NDRA News

InvestorsHub NewsWire

HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM

PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM

VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM

Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM

Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM

POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow